Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1292539 | 0.81 | PIK3CD (0.43) | PIK3CDMEN1KMT2A | |
| SCHEMBL9298293 | 0.80 | — | — | |
| SCHEMBL9298887 | 0.80 | — | — | |
| SCHEMBL6726808 | 0.78 | PIK3CD (0.32) | PIK3CDMEN1KMT2A | |
| SCHEMBL15745725 | 0.78 | PIK3CD (0.42) | PIK3CDMEN1KMT2A | |
| SCHEMBL11793063 | 0.78 | PIK3CD (0.42) | PIK3CDMEN1KMT2A | |
| SCHEMBL20267488 | 0.76 | PIK3CD (0.31) | PIK3CDMEN1KMT2A | |
| SCHEMBL19622377 | 0.75 | PIK3CD (0.33) | PIK3CDMEN1KMT2A | |
| SCHEMBL4967863 | 0.75 | PIK3CD (0.30) | PIK3CDMEN1KMT2A | |
| SCHEMBL20267861 | 0.75 | PIK3CD (0.30) | PIK3CDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3554559-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | Bracco Imaging SpA (IT) | 2019-10-23 | — | — | EP | claimed |
| WO-2018109164-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2018-06-21 | — | — | WO | claimed |
| US-20220054663-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2022-02-24 | — | — | US | disclosed |
| EP-3554559-B1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2022-02-02 | — | — | EP | disclosed |
| EP-3554559-B1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2022-02-02 | — | — | EP | disclosed |
| US-11160886-B2 | Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds | BRACCO IMAGING SPA (IT) | 2021-11-02 | — | — | US | disclosed |
| US-11160886-B2 | Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds | BRACCO IMAGING SPA (IT) | 2021-11-02 | — | — | US | disclosed |
| US-20200078479-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2020-03-12 | — | — | US | disclosed |
| EP-3554559-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | Bracco Imaging SpA (IT) | 2019-10-23 | — | — | EP | disclosed |
| WO-2018109164-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2018-06-21 | — | — | WO | disclosed |
| WO-2018109164-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | BRACCO IMAGING SPA (IT) | 2018-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200078479-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | PNP, TK1, NT5E | PIK3CD 1420/4885MEN1 999/4885KMT2A 4465/4885 |
| US-11160886-B2 | Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds | PNP, TK1, NT5E | PIK3CD 1420/4885MEN1 999/4885KMT2A 4465/4885 |
| US-20220054663-A1 | METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS | PNP, NT5E, TK1 | PIK3CD 1099/4885MEN1 580/4885KMT2A 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.